logo
Sensorion Announces Its Participation In Upcoming Investor Conferences

Sensorion Announces Its Participation In Upcoming Investor Conferences

Business Wire4 days ago
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced its participation in upcoming investor conferences to be held in September and October 2025.
Nawal Ouzren, Chief Executive Officer of Sensorion, and Laurene Danon, Chief Financial Officer, will attend the following events:
27th Annual H.C. Wainwright Global Investment Conference, to be held in New York City, USA, on September 8-10, 2025.
Baird 2025 Global Healthcare Conference, to be held in New York City, USA, on September 9-10, 2025.
European Midcap Event (CF&B), to be held at the Four Seasons Hôtel George V in Paris, France, on September 30 and October 1, 2025.
Portzamparc Biotech & Health Seminar, taking place virtually on October 1-2, 2025.
Chardan's 9 th Annual Genetic Medicines Conference, to be held in New York City, USA, on October 21, 2025.
If you would like to meet members of Sensorion's management team at any of these events, please contact us by email at ir.contact@sensorion-pharma.com.
About Sensorion
Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global unmet medical need. Sensorion has built a unique R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and mechanisms of action for drug candidates.
It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness, developed in the framework of its broad strategic collaboration focused on the genetics of hearing with the Institut Pasteur. SENS-501 (OTOF-GT) currently being developed in a Phase 1/2 clinical trial, targets deafness caused by mutations of the gene encoding for otoferlin and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses.
Sensorion's portfolio also comprises programs of a clinical-stage small molecule, SENS-401 (Arazasetron), for the treatment and prevention of hearing loss disorders. Sensorion's small molecule progresses in a Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) for the preservation of residual hearing. Sensorion, with partner Cochlear Limited, completed in 2024 a Phase 2a study of SENS-401 for the residual hearing preservation in patients scheduled for cochlear implantation. A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022.
www.sensorion.com
Disclaimer
This press release contains certain forward-looking statements concerning Sensorion and its business. Such forward looking statements are based on assumptions that Sensorion considers to be reasonable. However, there can be no assurance that such forward-looking statements will be verified, which statements are subject to numerous risks, including the risks set forth in the 2024 full year report published on March 14, 2025, and available on our website and to the development of economic conditions, financial markets and the markets in which Sensorion operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Sensorion or not currently considered material by Sensorion. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Sensorion to be materially different from such forward-looking statements. This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Sensorion shares in any country. The communication of this press release in certain countries may constitute a violation of local laws and regulations. Any recipient of this press release must inform oneself of any such local restrictions and comply therewith.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Business Wire

time15 minutes ago

  • Business Wire

Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP reminds investors of the upcoming September 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Flywire Corporation ('Flywire' or the 'Company') (NASDAQ: FLYW) securities between , inclusive (the 'Class Period'). IF YOU SUFFERED A LOSS ON YOUR FLYWIRE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS. What Happened? On February 25, 2025, after market hours, Flywire released its fourth quarter 2024 financial results, missing consensus estimates, citing 'a complex macro environment with significant headwinds' and stating that the Company's business in the education sector had significantly deteriorated due to worsening permit- and visa-related headwinds, including 'double digit declines in student visa issuance in our big four geographic markets,' with 'continued visa policy restrictions' anticipated in 2025. The Company further announced a restructuring plan that included a 10% reduction in its workforce. Additionally, the Company reduced its 2025 guidance. On this news, Flywire's stock price fell $6.59, or 37.4%, to close at $11.05 per share on February 26, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the strength and sustainability of Flywire's revenue growth was overstated; (2) the negative impact that permit- and visa-related restrictions were having and were likely to have on Flywire's business was understated; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Flywire securities during the Class Period, you may move the Court no later than September 23, 2025 to request appointment as lead plaintiff in this putative class action lawsuit. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150, Toll-Free: 888-773-9224 Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. If you inquire by email, please include your mailing address, telephone number and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

3Degrees Welcomes Matt Rogers to Board of Directors, Expresses Gratitude to April Salas For Four Years of Board Leadership
3Degrees Welcomes Matt Rogers to Board of Directors, Expresses Gratitude to April Salas For Four Years of Board Leadership

Business Wire

time15 minutes ago

  • Business Wire

3Degrees Welcomes Matt Rogers to Board of Directors, Expresses Gratitude to April Salas For Four Years of Board Leadership

SAN FRANCISCO--(BUSINESS WIRE)--3Degrees, a leading global climate solutions provider, is pleased to announce the appointment of Matt Rogers to its Board of Directors, effective August 1, 2025. Rogers brings 35 years of expertise serving clients globally in energy, sustainability, and innovation. 3Degrees also extends its deepest gratitude to outgoing board member April Salas, who is stepping down after more than four years of dedicated service. 'We are thrilled to welcome Matt to the 3Degrees Board of Directors,' said Philippe Vedrenne, CEO, 3Degrees. 'We are thrilled to welcome Matt to the 3Degrees Board of Directors,' said Philippe Vedrenne, CEO, 3Degrees. 'His track record of guiding companies through decarbonization and systems transformation makes him an exceptional partner as we support our clients in navigating their global climate action journey. We are looking forward to a fruitful collaboration, and know that Matt's insight and experience will be a tremendous asset to our team.' Over his more than 20 year career at McKinsey & Company, Rogers advised Fortune 500 companies, leading technology innovators, and energy providers worldwide. He also served in the U.S. Department of Energy, where he was responsible for implementing the energy investments of the American Recovery and Reinvestment Act. A widely recognized voice in the sector, Rogers has written and spoken extensively on topics including energy transitions, sustainability, power, and liquid fuels to boards, investors, and major global forums. He is a co-author of the book ' Resource Revolution: How to Capture the Biggest Business Opportunity in a Century ' and currently lectures at the Stanford Graduate School of Business and the Doerr School of Sustainability, as well as the UC Berkeley Haas School of Business. Rogers also serves on the Board of Directors of Exelon (NASDAQ: EXC) and is an Operating Partner at Ajax Strategies, a venture capital firm focused on climate innovation. In this capacity, he serves on the board of Natel Energy (fish-safe hydropower) and previously served on the boards of Ojjo (solar infrastructure) and Upstream Tech (AI for water and weather). 'The market and customers across the globe need 3Degrees more than ever right now," said Rogers. "I am looking forward to working with the full 3Degrees Board of Directors and management team to deliver increasing growth and impact.' In addition to welcoming Rogers, 3Degrees is also honoring the significant contributions of April Salas as she completes her tenure on the Board, which she joined in 2021. Salas brought a rare combination of cross-sectoral energy expertise, influenced by her leadership in federal energy policy, innovation, and academia. 'April's Board leadership helped shape a tremendous period of growth for 3Degrees,' said Dan Kalafatas, Chair of the Board, 3Degrees. 'She elevated our global, multi-sectoral, climate and energy expertise, and was an important partner during the company's strategic evolution as we deepened our decarbonization advisory capabilities, expanded internationally, launched new products and solutions, and sharpened our focus on measurable climate outcomes. We are grateful for her lasting contributions.'

Cognigy Announces Mastery Program to Meet Surging Demand for Agentic AI in the Contact Center
Cognigy Announces Mastery Program to Meet Surging Demand for Agentic AI in the Contact Center

Business Wire

time15 minutes ago

  • Business Wire

Cognigy Announces Mastery Program to Meet Surging Demand for Agentic AI in the Contact Center

DALLAS--(BUSINESS WIRE)-- Cognigy, the global leader in AI-first customer service automation, today announced the launch of its Mastery Program, a new set of advanced courses and certifications designed to meet the skyrocketing demand for Agentic AI in contact centers. This initiative empowers solution designers, developers, and implementation teams with the skills to build autonomous, enterprise-ready AI Agents that reason, decide, and act like humans—at scale. Agentic AI is rapidly redefining the customer service landscape. Cognigy's AI Agents are purpose-built for contact centers, capable of delivering fast, accurate, and hyper-personalized support while collaborating seamlessly with human agents. Now, the Cognigy Mastery Program ensures the people behind these AI Agents are just as capable. 'We're seeing massive demand for people who can actually build agentic systems, not just talk about them,' said Shanna Chauvin, Senior Director of Global GTM & Partner Enablement at Cognigy. 'The Mastery Program turns that need into opportunity—arming our community with the know-how to lead in this next era of customer service.' About the Program The Mastery Program consists of five hands-on technical courses that reflect real-world enterprise challenges in AI Agent design: Understanding the Message Lifecycle: Master how handles message flow, transformation, and execution. Integrating a Business Layer: Learn how to decouple logic from flow design using modular architecture. Multilingual AI Agents: Build agents that scale globally with consistent multilingual experiences. Publishing on Voice: Extend AI Agents into voice channels with best practices for deployment and optimization. Tracking & Reporting with Analytics: Use KPIs, OData, and Cognigy Insights to measure impact and tune performance. These courses are followed by a two-tier certification path: Specialist Certification: A multiple-choice exam validating foundational product knowledge. Master Builder Certification: A scenario-based, proctored exam conducted in-person, verifying expert-level skills in live solution design. 'This is a program for people who want to lead—not just launch AI Agents,' said Derek Roberti, VP of Technology at Cognigy. 'We've taken everything we've learned helping global brands deploy at scale and turned it into a clear, guided path for mastery.' Built for the Future of Contact Centers The Cognigy Mastery Program reflects Cognigy's broader commitment to professionalizing the AI Agent ecosystem. As demand surges for intelligent, autonomous agents across industries, enterprises need trusted teams who can deliver AI that works—securely, compliantly, and with measurable impact. Certified graduates of the Mastery Program become part of an elite community driving the AI-first transformation of contact centers worldwide. Availability The Cognigy Mastery Program is now open to all Cognigy customers and partners. To learn more or register, visit: About Cognigy Cognigy is transforming the customer service industry with the most advanced AI Agent platform for enterprise contact centers. Its award-winning solution, empowers enterprises to deliver instant, hyper-personalized, multilingual service on any channel. By integrating Generative and Conversational AI to create Agentic AI, Cognigy delivers AI Agents that redefine customer experiences, drive satisfaction, and support contact center employees in real-time. Over 1000 brands worldwide trust Cognigy and its vast partner network to create AI customer service agents for their contact center. Cognigy's impressive worldwide customer portfolio includes Bosch, Nestlé, DHL, Frontier Airlines, Lufthansa Group, Mercedes-Benz and Toyota. For more information and to book a demo visit: Follow the company on X (formerly Twitter) @Cognigy and on LinkedIn at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store